Tekla Healthcare Opportunities Fund THQ
We take great care to ensure that the data presented and summarized in this overview for Tekla Healthcare Opportunities Fund is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding THQ
View all-
Morgan Stanley New York, NY1.45MShares$28.1 Million0.0% of portfolio
-
Raymond James Financial Inc St. Petersburg, FL1.41MShares$27.5 Million0.01% of portfolio
-
Royal Bank Of Canada Toronto, A61.03MShares$20 Million0.0% of portfolio
-
Penserra Capital Management LLC Orinda, CA927KShares$18 Million0.34% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL740KShares$14.4 Million0.02% of portfolio
-
Raymond James & Associates St Petersburg, FL687KShares$13.3 Million0.01% of portfolio
-
Heron Bay Capital Management451KShares$8.77 Million1.85% of portfolio
-
Lpl Financial LLC Fort Mill, SC392KShares$7.62 Million0.0% of portfolio
-
Ubs Group Ag323KShares$6.27 Million0.0% of portfolio
-
Steward Partners Investment Advisory, LLC248KShares$4.82 Million0.04% of portfolio
Latest Institutional Activity in THQ
Top Purchases
Top Sells
About THQ
Tekla Healthcare Opportunities Fund is a closed ended balanced mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity and fixed income markets across the globe. It seeks to invest in securities of companies operating in the healthcare sector. The fund also invests in pooled investment vehicles. For its fixed income portion, the fund invests in corporate debt securities across the credit rating spectrum. It benchmarks the performance of its portfolio against the S&P 1500 Healthcare Index and S&P 500 Index. Tekla Healthcare Opportunities Fund was formed on April 2, 2014 and is domiciled in the United States.
Insider Transactions at THQ
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|
Jul 16
2024
|
Rose Di Martino Director |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$21,000
$21.3 P/Share
|
|
Apr 09
2024
|
Kathleen Goetz Director |
BUY
Open market or private purchase
|
Direct |
600
+34.32%
|
$11,400
$19.54 P/Share
|
|
Jan 02
2024
|
Todd Reit Director |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$18,000
$18.44 P/Share
|
|
Dec 28
2023
|
Bill Maher Director |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$18,000
$18.25 P/Share
|
|
Mar 23
2022
|
Kathleen Goetz Director |
BUY
Open market or private purchase
|
Direct |
69
+11.18%
|
$1,449
$21.68 P/Share
|
|
Jan 26
2022
|
Kathleen Goetz Director |
BUY
Open market or private purchase
|
Direct |
479
+50.0%
|
$10,059
$21.73 P/Share
|
|
Feb 25
2021
|
William S Reardon Director |
BUY
Open market or private purchase
|
Direct |
1,196
+50.0%
|
$23,920
$20.85 P/Share
|
Last 12 Months Summary
| Open market or private purchase | 1K shares |
|---|